The retained RB1 expression in these mCRPC cases, along with its loss in NEPC, suggests a driver role of RB1 protein loss in NEPC, further highlighted by the frequently observed concurrent loss of RB1 expression in the adenocarcinoma component in mixed PCA-NEPC [38,49]. This evidence concerns the gene RB1 and adenocarcinoma.